Mitsiades et al. [33] demonstrated that bortezomib phosphorylated and activated c-Jun through the JNK signaling pathway, which initiated the Fas apoptosis pathway and improved prognosis by promoting apoptosis of medullary thyroid carcinoma and undifferentiated thyroid cancer cells. The gene discussed is FAS; the disease is medullary thyroid gland carcinoma.